BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12972543)

  • 1. The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
    Maile LA; Badley-Clarke J; Clemmons DR
    Mol Biol Cell; 2003 Sep; 14(9):3519-28. PubMed ID: 12972543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
    Maile LA; Clemmons DR
    Circ Res; 2003 Nov; 93(10):925-31. PubMed ID: 14563713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor.
    Maile LA; Clemmons DR
    Endocrinology; 2002 Nov; 143(11):4259-64. PubMed ID: 12399420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
    Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOK1 mediates SHP-2 binding to the alphaVbeta3 integrin and thereby regulates insulin-like growth factor I signaling in cultured vascular smooth muscle cells.
    Ling Y; Maile LA; Badley-Clarke J; Clemmons DR
    J Biol Chem; 2005 Feb; 280(5):3151-8. PubMed ID: 15546884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2.
    Maile LA; Clemmons DR
    J Biol Chem; 2002 Mar; 277(11):8955-60. PubMed ID: 11779860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to changes in multiple signaling inputs.
    Clemmons DR; Maile LA
    Mol Endocrinol; 2005 Jan; 19(1):1-11. PubMed ID: 15528274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
    Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
    J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
    Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
    J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells.
    Lieskovska J; Ling Y; Badley-Clarke J; Clemmons DR
    J Biol Chem; 2006 Sep; 281(35):25041-53. PubMed ID: 16825188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system.
    Okazawa H; Motegi S; Ohyama N; Ohnishi H; Tomizawa T; Kaneko Y; Oldenborg PA; Ishikawa O; Matozaki T
    J Immunol; 2005 Feb; 174(4):2004-11. PubMed ID: 15699129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin-mediated tyrosine phosphorylation of SHPS-1 and its association with SHP-2. Roles of Fak and Src family kinases.
    Tsuda M; Matozaki T; Fukunaga K; Fujioka Y; Imamoto A; Noguchi T; Takada T; Yamao T; Takeda H; Ochi F; Yamamoto T; Kasuga M
    J Biol Chem; 1998 May; 273(21):13223-9. PubMed ID: 9582366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2.
    Oh ES; Gu H; Saxton TM; Timms JF; Hausdorff S; Frevert EU; Kahn BB; Pawson T; Neel BG; Thomas SM
    Mol Cell Biol; 1999 Apr; 19(4):3205-15. PubMed ID: 10082587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation.
    Takada T; Matozaki T; Takeda H; Fukunaga K; Noguchi T; Fujioka Y; Okazaki I; Tsuda M; Yamao T; Ochi F; Kasuga M
    J Biol Chem; 1998 Apr; 273(15):9234-42. PubMed ID: 9535915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the CD47-SHPS-1 system in regulation of cell migration.
    Motegi S; Okazawa H; Ohnishi H; Sato R; Kaneko Y; Kobayashi H; Tomizawa K; Ito T; Honma N; Bühring HJ; Ishikawa O; Matozaki T
    EMBO J; 2003 Jun; 22(11):2634-44. PubMed ID: 12773380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.
    Xi G; Shen X; Clemmons DR
    Mol Endocrinol; 2008 Sep; 22(9):2162-75. PubMed ID: 18606861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.
    Takeda H; Matozaki T; Fujioka Y; Takada T; Noguchi T; Yamao T; Tsuda M; Ochi F; Fukunaga K; Narumiya S; Yamamoto T; Kasuga M
    Oncogene; 1998 Jun; 16(23):3019-27. PubMed ID: 9662335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHP-2 complex formation with the SHP-2 substrate-1 during C2C12 myogenesis.
    Kontaridis MI; Liu X; Zhang L; Bennett AM
    J Cell Sci; 2001 Jun; 114(Pt 11):2187-98. PubMed ID: 11493654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation of the beta3-subunit of the alphaVbeta3 integrin is required for embrane association of the tyrosine phosphatase SHP-2 and its further recruitment to the insulin-like growth factor I receptor.
    Ling Y; Maile LA; Clemmons DR
    Mol Endocrinol; 2003 Sep; 17(9):1824-33. PubMed ID: 12791772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of B16 melanoma cells to CD47-induced negative regulation of motility as a result of aberrant N-glycosylation of SHPS-1.
    Ogura T; Noguchi T; Murai-Takebe R; Hosooka T; Honma N; Kasuga M
    J Biol Chem; 2004 Apr; 279(14):13711-20. PubMed ID: 14739297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.